Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Tax Provision
Samsung Biologics Co Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Tax Provision
-₩262.3B
|
CAGR 3-Years
-119%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Tax Provision
₩18.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Tax Provision
-₩379.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Tax Provision
-₩5.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Tax Provision
-₩11.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Tax Provision
₩2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Tax Provision?
Tax Provision
-262.3B
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Tax Provision amounts to -262.3B KRW.
What is Samsung Biologics Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
-27%
Over the last year, the Tax Provision growth was -24%. The average annual Tax Provision growth rates for Samsung Biologics Co Ltd have been -119% over the past three years , -27% over the past five years .